Comments
Novartis gets EU approval for Cushing's drug
25.04.2012. | ZURICH (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it has won European Union approval for its Signifor as the first medical therapy for Cushing's disease, a rare hormonal disorder....
